François Laliberté/LinkedIn
Aug 6, 2025, 12:52
RPTH Journal: Rivaroxaban vs Warfarin in PE with RV Dysfunction
RPTH Journal shared a new study on LinkedIn:
”Do clinical outcomes differ between patients treated with rivaroxaban vs warfarin for PE/RVD?
Rivaroxaban was more effective than warfarin without a significant increase in safety.”
Read the full article here.
Article: Effectiveness and safety of rivaroxaban vs warfarin in patients with pulmonary embolism and right ventricular dysfunction: a retrospective cohort study
Authors: François Laliberté, Behnood Bikdeli, Veronica Ashton, Guillaume Germain, Julien Boudreau, Manasvi Sundar, Sean D. MacKnight, Brahim Bookhart, Dereck Wentworth, Shawn Murphy, Yichuan G. Hsieh, Gregory Piazza
Find the latest scientific advances featured in Hemostasis Today.
Behnood Bikdeli
Brahim Bookhart
Dereck Wentworth
François Laliberté
Gregory Piazza
Guillaume Germain
Health
Hematology
Hemostasis Today
Julien Boudreau
Manasvi Sundar
Medicine
PE
Pulmonary embolism
right ventricular dysfunction
Rivaroxaban
Rivaroxaban vs Warfarin
RPTH Journal
RVD
Sean D. MacKnight
Shawn Murphy
Veronica Ashton
Warfarin
Yichuan G. Hsieh
-
Aug 6, 2025, 12:52RPTH Journal: Rivaroxaban vs Warfarin in PE with RV Dysfunction
-
Aug 6, 2025, 11:21Alexandru Stieber Shares NEJM Insights on Potential Combinations of Cytopenias
-
Aug 6, 2025, 10:58William Aird Explains Why Whales and Dolphins Lack Factor XII
-
Aug 6, 2025, 09:47Breaking Bias in Clinical Trials: Sabine Oertelt-Prigione and Brandon Turner Share Insights on Diversity, Sex, and Gender Representation
-
Aug 6, 2025, 06:37Seemant Chaturvedi: Could Tirofiban Improve Outcomes in Acute Ischemic Stroke?
-
Aug 6, 2025, 11:59NEW research from JTH: Stroke Risk and Prediction in Atrial Fibrillation
-
Aug 6, 2025, 10:47Conquering Factor VIII Inhibitors: New Insights Into the ‘Devil’ of Hemophilia A Treatment Resistance
-
Aug 6, 2025, 01:46Yara Dixon Shares Interesting Study on Heavy Menstrual Bleeding in Young Women
-
Aug 5, 2025, 19:27Ming Y Lim Presents the Clot Cases Conference: Model of Advanced Multidisciplinary Thrombosis Care
-
Aug 5, 2025, 18:49Francois Delvoye and Jean‐Philippe Désilles: Neutrophil Activation Affects Acute Ischemic Stroke Clinical Outcomes?
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Jul 26, 2025, 17:56HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Jul 13, 2025, 16:05EMA and HMA Mark a Key Step with 1st AI Observatory Report
-
Aug 5, 2025, 17:59Heghine Khachatryan: Honored to Be Part of The WFH Regional Workshop 2025
-
Aug 4, 2025, 05:20NBCA: Alexis’s DVT Diagnosis Came Without Warning - Learn How She Caught It Early
-
Aug 4, 2025, 00:50NBCA: After Losing Her Daughter to a Blood Clot, Charita Fights to Save Others
-
Aug 3, 2025, 18:10Andrew Agwunobi Congrats Dr. Oladipo Cole and The Whole Team at the Connecticut Bleeding Disorder Center
-
Aug 3, 2025, 12:03Elias Bouchi Presents Werfen EEMEA Talks on Hemostasis: Clot Stories Season 3
Aug 6, 2025, 12:52
Aug 6, 2025, 11:59
Aug 6, 2025, 10:58